Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (6)
Type
(
1 selected
)
Type
Guidance (1904)
NICE advice (320)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (225)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (603)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (341)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (797)
Apply filters
Showing 481 to 490 of 1904
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
PredictSURE IBD and IBDX to guide treatment of Crohn's disease
DG45
23 February 2022
23 February 2022
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules
DG46
23 February 2022
23 February 2022
Odevixibat for treating progressive familial intrahepatic cholestasis
HST17
22 February 2022
22 February 2022
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer
TA770
9 February 2022
9 February 2022
Daratumumab with bortezomib, melphalan and prednisone for untreated multiple myeloma (terminated appraisal)
TA771
9 February 2022
9 February 2022
Olaparib for treating BRCA mutation-positive HER2-negative metastatic breast cancer after chemotherapy (terminated appraisal)
TA762
2 February 2022
2 February 2022
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitable
TA763
2 February 2022
2 February 2022
Fremanezumab for preventing migraine
TA764
2 February 2022
2 February 2022
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable
TA765
2 February 2022
2 February 2022
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanoma
TA766
2 February 2022
2 February 2022
Previous page
1
…
47
48
Current page
49
50
51
…
191
Page
49
of
191
Next page
Results per page
10
25
50
All
Back to top